SNDX-5613 T12943
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
SNDX-5613 is a potent and specific inhibitor of Menin-MLL(Ki of 0.149 nM and a cell based IC50 of 10-20 nM). SNDX-5613 can be used for the research of MLL-rearranged (MLL-r) acute leukemias.
CAS nr:
2169919-21-3
Purity:
98%
Molecular Weight:
630,82
SMILES:
O=C(C1=CC(F)=CC=C1OC2=CN=CN=C2N3CC4(C3)CCN(CC4)C[C@H]5CC[C@@H](CC5)NS(=O)(CC)=O)N(C(C)C)CC
Formula:
C32H47FN6O4S
Pathway:
Chromatin/Epigenetic,Chromatin/Epigenetic
Target:
Epigenetic Reader Domain,Histone Methyltransferase
